Securidaca–saponins are natural inhibitors of AKT, MCL-1, and BCL2L1 in cervical cancer cells TC Obasi, C Braicu, BC Iacob, E Bodoki, A Jurj, L Raduly, I Oniga, ... Cancer Management and Research, 5709-5724, 2018 | 21 | 2018 |
Molecular-trapping in emulsion’s monolayer: a new strategy for production and purification of bioactive saponins TC Obasi, R Moldovan, A Toiu, C Braicu, E Bodoki, I Berindan-Neagoe, ... Scientific Reports 7 (1), 14511, 2017 | 14 | 2017 |
Free radical scavenging activity and total polyphenol content of Securidaca longipedunculata roots and leaves extracts TC Obasi, D Benedec, D Hanganu, AM Gheldiu, L Vlase, I Oniga, ... Farmacia 68 (1), 116-120, 2020 | 8 | 2020 |
Abstract A58: HR-ESI-MS identification of novel triterpenoid antitumor substances in securidaca 1, using activity-guided SRB assay TC Obasi, R Oprean Clinical Cancer Research 26 (13_Supplement), A58-A58, 2020 | | 2020 |
HR-ESI-MS identification of novel triterpenoid antitumor substances in securidaca 1, using activity-guided SRB assay. TC Obasi, R Oprean CLINICAL CANCER RESEARCH 26 (13), 68-68, 2020 | | 2020 |
Natural Pro-apoptotic Agents from Securidaca Longipedunculata TC Obasi | | 2020 |
Securidaca–saponins are natural inhibitors of AKT, MCL-1, and BCL2L1 in cervical cancer cells [Corrigendum] TC Obasi, C Braicu, BC Iacob Cancer Management and Research 11, 691, 2019 | | 2019 |
Securidaca1 and 2 induced apoptosis: A PI3K-AKT dependent pathway in cervical cancer TC Obasi, C Braicu, H Noack, I Berindan-Neagoe, B Junker, RN Oprean Cancer Research 78 (13_Supplement), 2673-2673, 2018 | | 2018 |